Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Sudarshan Sukhani of s2analytics.com recommends buying Bharat Petroleum Corporation and Aurobindo Pharma and advises selling Mindtree.
Ashwani Gujral of ashwanigujral.com recommends buying Bajaj Finance, Biocon and Bharat Petroleum Corporation.
The brokerage house has maintained buy rating on them with revised target price at Rs 1,635 per share (from Rs 1,250 earlier) on Hindustan Petroleum Corporation, Rs 700 (from Rs 540) on Indian Oil Corporation and Rs 740 (from Rs 640) on Bharat Petroleum Corporation.
According to Sandeep Wagle of powermywealth.com, one can sell Dish TV and Bharat Petroleum Corporation and buy Bharti Airtel.
Credit Suisse maintains an outperform rating on Bharat Petroleum (BPCL) with a target price of Rs 600. The brokerage house bases its positive rating on the state-run refiner‘s focus on four key non-fuel initiatives.
Avinash Gorakshakar, Market Expert is of the view that one may prefer Indian Oil Corporation (IOC) or Bharat Petroleum Corporation over Aban Offshore.
Sudarshan Sukhani of s2analytics.com is of the view that one may see imminent break out in BPCL and has Glenmark Pharma as the choice for the day.
SP Tulsian of sptulsian.com, in an interview to CNBC-TV18 shares his views on refrigerants companies, transformer makers and media reports on mergers in the PSU oil space.
Sandeep Wagle of powermywealth.com recommends buying IGL, NCC and BPCL and feels that DLF will outperform.
Sandeep Wagle of powermywealth.com recommends buying Cadila Healthcare, ACC, Torrent Pharma and BPCL.
Sandeep Wagle of powermywealth.com recommends buying Aurobindo Pharma, Voltas and Bharat Petroleum Corporation.
Ashwani Gujral of ashwanigujral.com recommends buying NIIT Tech, Chennai Petroleum and NBCC.
Sudeep Anand, IDBI Capital Markets Services believe with reduction in under recoveries rerating of upstream companies is on the cards.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy ICICI Bank, Hero MotoCorp and Bharat Petroleum Corporation.
VK Sharma of HDFC Securities isof the view that one can buy Bharat Petroleum Corporation 1120 Call and Hindustan Petroleum Corporation 1050 Call.
Nischal Maheshwari, Head - Institutional Equities at Edelweiss Securities has a positive view on oil marketing companies and feels that the stocks can give 20-25 percent kind of return from these levels.
In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks for the day and talked about the listing of Mahanagar Gas on the Indian bourse.
CA Rudramurthy BV of Vachana Investments is of the view that one can buy Housing Development and Infrastructure, Tata Global Beverage and Bharat Petroleum Corporation.
Though 7th pay hike is lower than in 6th Pay Commission and the arrear payouts are likely to be lower, analysts still expect a consumption boost. Citi economists expect consumption growth pick up to 8.4 percent in FY17 from 7.6 percent in FY16 (marginal downside risks from potential delays in implementation of allowances hike).
Prakash Gaba of prakashgaba.com is of the view that Ashok Leyland may test Rs 102 while Sun Pharma may hit Rs 805 and Jain Irrigation may head to Rs 80.
Sudarshan Sukhani of s2analytics.com recommends buying Bharat Petroluem Corporation, Power Grid and Biocon.
On Friday, the day of Brexit referendum results, the benchmark Sensex lost nearly 1,100 points intra-day before closing 604.51 points lower. Investors' wealth in stock market took a hit of nearly Rs 1.8 lakh crore on that day.
Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharmaceutical Industries, Bharat Petroleum Corporation and Hindustan Petroleum Corporation and advises selling UPL and Bata India.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Bharat Petroleum Corporation.
Ashwani Gujral of ashwanigujral.com recommends buying Bharat Petroleum Corporation and Ambuja Cements and advises selling UPL.